NORTHERN TRUST CORP - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,755,937
-1.5%
504,956
+2.9%
0.00%0.0%
Q2 2023$8,893,133
+222.5%
490,791
+373.4%
0.00%
+100.0%
Q1 2023$2,757,542
+75.3%
103,667
+27.4%
0.00%
Q4 2022$1,572,921
+33.8%
81,372
+44.5%
0.00%
Q3 2022$1,176,000
+289.4%
56,301
+49.1%
0.00%
Q2 2022$302,000
-79.8%
37,761
-82.3%
0.00%
Q1 2022$1,498,000
-51.4%
213,669
-6.5%
0.00%
-100.0%
Q4 2021$3,084,000
-18.7%
228,451
+1.6%
0.00%0.0%
Q3 2021$3,795,000
-39.7%
224,820
+4.0%
0.00%0.0%
Q2 2021$6,293,000
-28.0%
216,122
-2.7%
0.00%
-50.0%
Q1 2021$8,735,000
+216.3%
222,092
+82.7%
0.00%
+100.0%
Q4 2020$2,762,000
+0.6%
121,536
+0.3%
0.00%0.0%
Q3 2020$2,745,000121,2140.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 5,839,160$98,565,00018.71%
CHI Advisors LLC 2,484,724$41,942,00012.24%
TRV GP IV, LLC 2,132,867$36,003,0008.17%
Bond & Devick Financial Network, Inc. 120,160$2,028,0001.68%
Fernwood Investment Management, LLC 166,447$2,810,0000.96%
Redmile Group, LLC 3,083,501$52,049,0000.91%
HARVARD MANAGEMENT CO INC 562,379$9,493,0000.56%
Grace Capital 48,058$808,0000.50%
Eventide Asset Management 2,183,238$36,853,0000.49%
Cormorant Asset Management, LP 482,413$8,143,0000.33%
View complete list of PLIANT THERAPEUTICS INC shareholders